Top Buy Stocks: ABBV, CVE, CVS, GNMX, NLY, XLU

NYSE: ABBV (Abbvie Inc)

NYSE: ABBV (Abbvie Inc) has closed at $96.48, its traded Volume was 9137.9K shares, ABBV opened the Day at $95.5, it made an intraday Low of $94.51, and an intraday High of $96.62. ABBV’s close price is above its Short term MA, short term MA is above mid-term, and above long term MA. ABBV (Abbvie Inc) 52-week High is $96.62, 52-week Low is: $55.06, it has supports at $79.84 and $69.47, resistances at $96.62 and $112.85. ABBV’s earning is $4.07 per share, Next quarter estimated EPS is $1.44, current year estimated EPS is $5.53. Its PE ratio is 24. Overall, this stock is rated BUY today.

NYSE: CVE (Cenovus Energy Inc)

NYSE: CVE (Cenovus Energy Inc) has closed at $10.01, its traded Volume was 6628.3K shares, CVE opened the Day at $9.75, it made an intraday Low of $9.71, and an intraday High of $10.05. CVE’s close price is above its Short term MA, short term MA is above mid-term, and above long term MA. CVE (Cenovus Energy Inc) 52-week High is $16.82, 52-week Low is: $6.76, it has supports at $8.57 and $7.28, resistances at $10.68 and $12.47. CVE’s earning is $2.45 per share, Next quarter estimated EPS is $0.1, current year estimated EPS is $0.48. Its PE ratio is 4. Overall, this stock is rated BUY today.

NYSE: CVS (CVS Corp)

NYSE: CVS (CVS Corp) has closed at $74.63, its traded Volume was 8015.49K shares, CVS opened the Day at $74.26, it made an intraday Low of $74.2, and an intraday High of $75.2. CVS’s close price is below its Short term MA, short term MA is below mid-term, and below long term MA. CVS (CVS Corp) 52-week High is $88.58, 52-week Low is: $69.3, it has supports at $72.12 and $60, resistances at $79.46 and $84. CVS’s earning is $5.02 per share, Next quarter estimated EPS is $1.91, current year estimated EPS is $5.88. Its PE ratio is 15. Overall, this stock is rated BUY today.

NASDAQ: GNMX (Aevi Genomic Medicine)

NASDAQ: GNMX (Aevi Genomic Medicine) has closed at $1.61, its traded Volume was 8775.35K shares, GNMX opened the Day at $1.34, it made an intraday Low of $1.3, and an intraday High of $1.91. GNMX’s close price is above its Short term MA, short term MA is above mid-term, and above long term MA. GNMX (Aevi Genomic Medicine) 52-week High is $17.75, 52-week Low is: $0.98, it has supports at $1.43 and $1.14, resistances at $1.9 and $2.21. GNMX’s earning is $-1.02 per share, Next quarter estimated EPS is $-0.16, current year estimated EPS is $-0.85. Its PE ratio is -2. Overall, this stock is rated STRONG BUY today.

NYSE: NLY (Annaly Capital Management Inc)

NYSE: NLY (Annaly Capital Management Inc) has closed at $12.37, its traded Volume was 7248.62K shares, NLY opened the Day at $12.3, it made an intraday Low of $12.26, and an intraday High of $12.38. NLY’s close price is above its Short term MA, short term MA is below mid-term, and below long term MA. NLY (Annaly Capital Management Inc) 52-week High is $12.73, 52-week Low is: $9.83, it has supports at $12.23 and $12.02, resistances at $12.57 and $14.68. NLY’s earning is $2.89 per share, Next quarter estimated EPS is $0.3, current year estimated EPS is $1.2. Its PE ratio is 4. Overall, this stock is rated BUY today.

AMEX: XLU (S&P 500 Utilities Sector SPDR)

AMEX: XLU (S&P 500 Utilities Sector SPDR) has closed at $54.82, its traded Volume was 10273.5K shares, XLU opened the Day at $54.35, it made an intraday Low of $54.29, and an intraday High of $54.82. XLU’s close price is above its Short term MA, short term MA is below mid-term, and above long term MA. XLU (S&P 500 Utilities Sector SPDR) 52-week High is $55.9, 52-week Low is: $45.33, it has supports at $53.83 and $52.56, resistances at $55.9 and $65.29. XLU’s earning is $7.59 per share, Next quarter estimated EPS is $0, current year estimated EPS is $1.67. Its PE ratio is 7. Overall, this stock is rated BUY today.

About the Author

has written 15967 stories on this site.

Write a Comment

Gravatars are small images that can show your personality. You can get your gravatar for free today!

You must be logged in to post a comment.

Copyright © 2012 Nine Stocks